deltatrials
Completed PHASE1/PHASE2 INTERVENTIONAL 1-arm NCT01389661

Treatment Of Maxillary Bone Cysts With Autologous Bone Mesenchymal Stem Cells (MSV-H) (BIOMAX)

Regeneration of Maxillary Bone Cystic Cavities by Bio Implant of MSHV-H Cells Associated to a Cross-linked Serum Scaffold

Sponsor: Centro en Red de Medicina Regenerativa de Castilla y Leon

Conditions Bone Loss of Substance Maxillary Cyst
Interventions MSV treatment
Updated 8 times since 2017 Last updated: Apr 25, 2017 Started: Apr 30, 2011 Primary completion: Apr 25, 2016 Completion: Apr 25, 2016
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1/PHASE2 clinical study on Bone Loss of Substance and Maxillary Cyst, this trial is completed. The trial is conducted by Centro en Red de Medicina Regenerativa de Castilla y Leon and has accumulated 8 data snapshots since 2011. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jan 2017 – ~May 2017 · 4 months · monthly snapshotActive Not Recruiting~May 2017 – ~Jun 2018 · 13 months · monthly snapshotCompleted~Jun 2018 – ~Sep 2020 · 27 months · monthly snapshotCompleted~Sep 2020 – ~Jan 2021 · 4 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotCompleted~Sep 2025 – present · 10 months · monthly snapshotCompleted

Change History

8 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE1/PHASE2

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE1/PHASE2

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE1/PHASE2

    Phase: PHASE1_PHASE2 → PHASE1/PHASE2

  4. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE1_PHASE2

  5. Sep 2020 — Jan 2021 [monthly]

    Completed PHASE1_PHASE2

▶ Show 3 earlier versions

  1. Jun 2018 — Sep 2020 [monthly]

    Completed PHASE1_PHASE2

  2. May 2017 — Jun 2018 [monthly]

    Completed PHASE1_PHASE2

    Status: Active Not Recruiting → Completed

  3. Jan 2017 — May 2017 [monthly]

    Active Not Recruiting PHASE1_PHASE2

    First recorded

Apr 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Centro en Red de Medicina Regenerativa de Castilla y Leon
  • Citospin
  • Red de Terapia Celular
  • Sanidad de Castilla y León
  • University of Valladolid
Data source: Red de Terapia Celular

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations